Study to Evaluate the Efficacy and Safety of Tegoprazan in ERD Patients With Nighttime Heartburn and Sleep Disturbance

NCT04309916 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Erosive Reflux Disease

Interventions

DRUG: Tegoprazan
DRUG: Esomeprazole

Sponsor

HK inno.N Corporation